Hoping to answer a question raised by the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study, UT Southwestern Medical Center researchers have designed the Combining Medication to Enhance Outcomes of Depression (CO-MED) trial to test multiple-medication treatment of depression. “We are trying two active, Food and Drug Administration-marketed antidepressant medicines available by prescription from your local drugstore,” said Dr.
Popularity: unranked [?]
Related posts:
- New Genetic Test Identifies Patients At Risk Of Suicide, Makes Antidepressant Drugs Safer
- U.S. Food And Drug Administration Approves ABILIFY(R) (aripiprazole) As The First Medication For Add-On Treatment Of Major Depressive Disorder (MDD)
- Suicide Behavior FDA Public Health Advisory For Chantix – Smoking Cessation Drug
- ABILIFY® (aripiprazole) Supplemental New Drug Application Receives Priority Review By U.S. Food And Drug Administration For Depression Disorder
- Europe Wants Warnings On Champix Smoking Cessation Drug
Comments
No Responses to “CO-MED Trial: Two-Drug Test Approach To Depression”